Charles Schwab
CLMT icon

Charles Schwab’s Calumet Specialty Products CLMT Stock Holding History

Charles Schwab’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.9M Buy
552,791
+12,124
+2% +$408K ﹤0.01% 1831
2026
Q1 		$19.4M Sell
540,667
-9,829
-2% -$254K ﹤0.01% 1763
2025
Q4 		$10.9M Sell
550,496
-5,237
-0.9% -$101K ﹤0.01% 2090
2025
Q3 		$10.1M Sell
555,733
-15,272
-3% -$251K ﹤0.01% 2113
2025
Q2 		$9M Buy
571,005
+175,100
+44% +$2.23M ﹤0.01% 2069
2025
Q1 		$5.02M Sell
395,905
-9,792
-2% -$154K ﹤0.01% 2267
2024
Q4 		$8.93M Buy
405,697
+4,496
+1% +$94.5K ﹤0.01% 2069
2024
Q3 		$7.15M Buy
+401,201
New +$6.43M ﹤0.01% 2187

Other funds holding CLMT

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WDOM
Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Charles Schwab's CLMT Position: Q2 2026 in Review

Charles Schwab increased its Calumet Specialty Products (CLMT) stake by 2.2% in Q2 2026, buying an estimated $408K and bringing the position to 552,791 shares worth $19.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1831.

Charles Schwab first reported a position in CLMT in Q3 2024 and has held it in 8 quarters since. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • Charles Schwab held 552,791 shares of Calumet Specialty Products worth $19.9M as of Q2 2026.
  • Charles Schwab bought 12,124 Calumet Specialty Products shares in Q2 2026, an estimated $408K.
  • Calumet Specialty Products made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #1831 holding.
  • Charles Schwab first reported a position in Calumet Specialty Products in Q3 2024 and has held it in 8 quarters since.
  • 188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.